✦ LIBER ✦

A crossover comparative study of aminoglutethimide vs trilostane in advanced postmenopausal breast cancer

✍ Scribed by Williams, C.; Barley, V.; Blackledge, G.; Rowland, C.; Tyrell, C.; Bachelot, F.; Demaille, A.; Guerrin, J.; Nadman, H.; Namer, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low-dose aminoglutethimide in treatment

✍ K. Höffken; A. A. Miller; B. Miller; B. Hoffmann; R. Becher; E. Aulbert; B. Scho 📂 Article 📅 1986 🏛 Springer-Verlag 🌐 English ⚖ 128 KB

Trilostane in the treatment of advanced

✍ C. G. Beardwell; A. C. Hindley; P. M. Wilkinson; I. D. H. Todd; G. G. Ribeiro; d 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 284 KB

Aminoglutethimide (AG) in advanced breas

✍ H. J. Illiger; H. Caffier; H. Carterier; B. Eggeling; J. Hartlapp; C. Hartwich; 📂 Article 📅 1986 🏛 Springer-Verlag 🌐 English ⚖ 128 KB

Clinical Trial of Letrozole (femara) ver

✍ Xiaoqing LIU; Santai SONG; Zefei JIANG; Weilian LI; Weixia WANG; Hui YANG 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 84 KB

Phase II study of low dose aminoglutethi

✍ Harris, Adrian L.; Cantwell, Brian M.J.; Carmichael, James; Dawes, Peter; Robins 📂 Article 📅 1989 🏛 Elsevier Science ⚖ 712 KB

Trilostane plus hydrocortisone in postme

✍ T'Hooft-Andry, M.; Focan, C.; Clarysse, A.; Michel, J.; Heuson, J.C.; Paridaens, 📂 Article 📅 1986 🏛 Elsevier Science ⚖ 153 KB